Details for New Drug Application (NDA): 212868
✉ Email this page to a colleague
NDA 212868 describes ATROPINE SULFATE, which is a drug marketed by Us Army, Amneal, Apotex, Bausch And Lomb Inc, Mankind Pharma, Rising, Somerset, Somerset Theraps Llc, Accord Hlthcare, Am Regent, Hikma, Hospira, Intl Medication Sys, Medefil Inc, and Fresenius Kabi Usa, and is included in twenty-one NDAs. It is available from twenty-four suppliers. Additional details are available on the ATROPINE SULFATE profile page.
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 212868
| Tradename: | ATROPINE SULFATE |
| Applicant: | Accord Hlthcare |
| Ingredient: | atropine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 212868
| Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 212868
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 212868 | ANDA | Accord Healthcare, Inc., | 16729-483 | 16729-483-03 | 10 SYRINGE, GLASS in 1 CARTON (16729-483-03) / 5 mL in 1 SYRINGE, GLASS |
| ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 212868 | ANDA | Accord Healthcare, Inc., | 16729-483 | 16729-483-31 | 5 mL in 1 SYRINGE, GLASS (16729-483-31) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.25MG/5ML (0.05MG/ML) | ||||
| Approval Date: | Jul 26, 2021 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.5MG/5ML (0.1MG/ML) | ||||
| Approval Date: | Jul 26, 2021 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1MG/10ML (0.1MG/ML) | ||||
| Approval Date: | Jul 26, 2021 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
